<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9705402</journal-id>
<journal-id journal-id-type="pubmed-jr-id">20436</journal-id>
<journal-id journal-id-type="nlm-ta">Cell Mol Life Sci</journal-id>
<journal-id journal-id-type="iso-abbrev">Cell. Mol. Life Sci.</journal-id>
<journal-title-group>
<journal-title>Cellular and molecular life sciences : CMLS</journal-title>
</journal-title-group>
<issn pub-type="ppub">1420-682X</issn>
<issn pub-type="epub">1420-9071</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29779043</article-id>
<article-id pub-id-type="pmc">6123274</article-id>
<article-id pub-id-type="doi">10.1007/s00018-018-2841-9</article-id>
<article-id pub-id-type="manuscript">NIHMS981309</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>GLIS1-3 transcription factors: critical roles in the regulation of multiple physiological processes and diseases</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Jetten</surname>
<given-names>Anton M.</given-names>
</name>
<aff id="A1">Cell Biology Group, Immunity, Inflammation and Disease Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709, USA</aff>
</contrib>
</contrib-group>
<author-notes>
<corresp id="CR1">Address correspondence to: Anton M. Jetten, <email>jetten@niehs.nih.gov</email>, Tel: 919-541-2768</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>25</day>
<month>7</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>19</day>
<month>5</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>10</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>10</month>
<year>2018</year>
</pub-date>
<volume>75</volume>
<issue>19</issue>
<fpage>3473</fpage>
<lpage>3494</lpage>
<!--elocation-id from pubmed: 10.1007/s00018-018-2841-9-->
<abstract id="ABS1">
<p id="P1">Krüppel-like zinc finger proteins form one of the largest families of transcription factors. They function as key regulators of embryonic development and a wide range of other physiological processes, and are implicated in a variety of pathologies. GLI-Similar 1–3 (GLIS1–3) constitute a subfamily of Krüppel-like zinc finger proteins that act either as activators or repressors of gene transcription. GLIS3 plays a critical role in the regulation of multiple biological processes and is a key regulator of pancreatic β cell generation and maturation, insulin gene expression, thyroid hormone biosynthesis, spermatogenesis, and the maintenance of normal kidney functions. Loss of GLIS3 function in humans and mice leads to the development of several pathologies, including neonatal diabetes and congenital hypothyroidism, polycystic kidney disease, and infertility. Single nucleotide polymorphisms in <italic>GLIS3</italic> genes have been associated with increased risk of several diseases, including type 1 and type 2 diabetes, glaucoma, and neurological disorders. GLIS2 plays a critical role in the kidney and GLIS2 dysfunction leads to nephronophthisis, an end-stage, cystic renal disease. In addition, GLIS1–3 have regulatory functions in several stem/progenitor cell populations. GLIS1 and GLIS3 greatly enhance reprogramming efficiency of somatic cells into induced embryonic stem cells, while GLIS2 inhibits reprogramming. Recent studies have obtained substantial mechanistic insights into several physiological processes regulated by GLIS2 and GLIS3, while little is still known about the physiological functions of GLIS1. The localization of some GLIS proteins to the primary cilium suggests that their activity may be regulated by a downstream primary cilium-associated signaling pathway. Insights into the upstream GLIS signaling pathway may provide opportunities for the development of new therapeutic strategies for diabetes, hypothyroidism, and other diseases.</p>
</abstract>
<kwd-group>
<kwd>GLIS1</kwd>
<kwd>GLIS2</kwd>
<kwd>GLIS3</kwd>
<kwd>Krüppel-like zinc finger protein</kwd>
<kwd>pancreatic beta cells</kwd>
<kwd>diabetes</kwd>
<kwd>insulin</kwd>
<kwd>polycystic kidney disease</kwd>
<kwd>nephronophthisis</kwd>
<kwd>primary cilium</kwd>
<kwd>reprogramming</kwd>
<kwd>stem cells</kwd>
<kwd>hypothyroidism</kwd>
<kwd>spermatogenesis</kwd>
<kwd>thyroid hormone biosynthesis</kwd>
<kwd>NIS</kwd>
<kwd>development</kwd>
<kwd>HECT E3 ubiquitin ligase</kwd>
<kwd>TAZ</kwd>
<kwd>SUFU</kwd>
<kwd>ITCH</kwd>
<kwd>GWAS</kwd>
<kwd>mutations</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>